000			02165 a2200661 4500
005			20250517070455.0
264		0	_c20170731
008			201707s 0 0 eng d
022			_a1473-1150
024	7		_a10.1038/tpj.2015.87 _2doi
040			_aNLM _beng _cNLM
100	1		_aSanghavi, K
245	0	0	_aGenotype-guided tacrolimus dosing in African-American kidney transplant recipients. _h[electronic resource]
260			_bThe pharmacogenomics journal _c01 2017
300			_a61-68 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study; Observational Study; Research Support, N.I.H., Extramural
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aBlack or African American _xgenetics
650	0	4	_aAged
650	0	4	_aCalcineurin Inhibitors _xadministration & dosage
650	0	4	_aCanada _xepidemiology
650	0	4	_aCytochrome P-450 CYP3A _xgenetics
650	0	4	_aDrug Dosage Calculations
650	0	4	_aFemale
650	0	4	_aGene Frequency
650	0	4	_aGenotype
650	0	4	_aGraft Rejection _xethnology
650	0	4	_aGraft Survival _xdrug effects
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xadministration & dosage
650	0	4	_aKidney Transplantation _xadverse effects
650	0	4	_aMale
650	0	4	_aMetabolic Clearance Rate _xgenetics
650	0	4	_aMiddle Aged
650	0	4	_aModels, Genetic
650	0	4	_aPharmacogenetics
650	0	4	_aPharmacogenomic Testing
650	0	4	_aPharmacogenomic Variants
650	0	4	_aPhenotype
650	0	4	_aTacrolimus _xadministration & dosage
650	0	4	_aTransplant Recipients
650	0	4	_aTreatment Outcome
650	0	4	_aUnited States _xepidemiology
650	0	4	_aYoung Adult
700	1		_aBrundage, R C
700	1		_aMiller, M B
700	1		_aSchladt, D P
700	1		_aIsrani, A K
700	1		_aGuan, W
700	1		_aOetting, W S
700	1		_aMannon, R B
700	1		_aRemmel, R P
700	1		_aMatas, A J
700	1		_aJacobson, P A
773	0		_tThe pharmacogenomics journal _gvol. 17 _gno. 1 _gp. 61-68
856	4	0	_uhttps://doi.org/10.1038/tpj.2015.87 _zAvailable from publisher's website
999			_c25541953 _d25541953